Gender and sex differences in colorectal cancer screening, diagnosis and treatment
Clinical and Translational Oncology · 17.01.2025 · 27 (7) · 2825-2837
DOI: 10.1007/s12094-024-03801-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 17.01.2025. Verfasst von Encarnación González-Flores und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Av. de las Fuerzas Armadas, 2, Beiro, 18014, Granada, Spain. encarnagonz…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Sex Characteristics. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sociedad Española de Oncología Médica.
Abstract (Originalsprache)
Males have a higher incidence and mortality rate from colorectal cancer (CRC) compared with females. This review examines the reasons for these differences, including risk factors, screening participation, interpretation of screening tests, presentation and tumour types, pathophysiology (particularly the impact of sex hormones on tumour-related gene expression, microsatellite instability, micro-RNA expression, and the tumour microenvironment), and the efficacy and toxicity of treatment. Sex differences in hormones and body composition are responsible for some of the sexual dimorphism in CRC incidence and outcomes, particularly the pathophysiology, CRC presentation, the pharmacokinetics of cytotoxic therapies, and the impact of treatment on outcomes. However, gender differences also play a role, affecting risk factors, access to or participation in screening and treatment, and patients’ experience of treatment (e.g. adverse events and sequelae). Sex and gender issues warrant further investigation in CRC to optimise treatment outcomes for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Av. de las Fuerzas Armadas, 2, Beiro, 18014, Granada, Spain. encarnagonzalezflores@gmail.com.
- Instituto de Investigación biosanitaria.ibs.granada, Granada, Spain. encarnagonzalezflores@gmail.com.
- Department of Medical Oncology, Hospital Universitario 12 de Octubre, Imas12, Medicine Faculty, Universidad Complutense Madrid (UCM), Madrid, Spain.
- Department of Medical Oncology, Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
- Instituto de Investigación biosanitaria.ibs.granada, Granada, Spain.
- Department of Gastroenterology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Förderung
- Sociedad Española de Oncología Médica
Zitieren
APA
González-Flores, E., Garcia-Carbonero, R., Élez, E., Redondo-Cerezo, E., Safont, M. J., & Vera García, R. (2025). Gender and sex differences in colorectal cancer screening, diagnosis and treatment. Clinical and Translational Oncology, 27(7), 2825-2837. https://doi.org/10.1007/s12094-024-03801-0
Vancouver
González-Flores E, Garcia-Carbonero R, Élez E, Redondo-Cerezo E, Safont MJ, Vera García R. Gender and sex differences in colorectal cancer screening, diagnosis and treatment. Clinical and Translational Oncology. 2025;27(7):2825-2837. doi:10.1007/s12094-024-03801-0
BibTeX
@article{GonzlezFlores2025,
author = {González-Flores, Encarnación and Garcia-Carbonero, Rocio and Élez, Elena and Redondo-Cerezo, Eduardo and Safont, María José and Vera García, Ruth},
title = {Gender and sex differences in colorectal cancer screening, diagnosis and treatment},
journal = {Clinical and Translational Oncology},
year = {2025},
volume = {27},
number = {7},
pages = {2825--2837},
doi = {10.1007/s12094-024-03801-0}
}
EUVIMED